{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:55:02Z","timestamp":1780923302374,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T00:00:00Z","timestamp":1210032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11102-008-0126-2","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T13:14:52Z","timestamp":1209993292000},"page":"279-285","source":"Crossref","is-referenced-by-count":56,"title":["Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study"],"prefix":"10.1007","volume":"11","author":[{"given":"Karina","family":"Danilowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Domingo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Manavela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynaldo Manuel","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"126_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.2003.01799.x","volume":"59","author":"IA Malik","year":"2003","unstructured":"Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA (2003) Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clin Endocrinol (Oxf) 59:75\u201381. doi: 10.1046\/j.1365-2265.2003.01799.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR2","first-page":"1600","volume":"87","author":"AF Attanasio","year":"2002","unstructured":"Attanasio AF, Bates PC, Ho KK et al (2002) Hypoptiuitary control and complications study international advisory board. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. J Clin Endocrinol Metab 87:1600\u20131606. doi: 10.1210\/jc.87.4.1600","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bmj.1.6007.448","volume":"1","author":"GM Besser","year":"1976","unstructured":"Besser GM, Jeffcoate WJ (1976) Endocrine and metabolic diseases. Adrenal diseases. BMJ 1:448\u2013451","journal-title":"BMJ"},{"key":"126_CR4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/014107688808100906","volume":"81","author":"RW Groves","year":"1988","unstructured":"Groves RW, Toms GC, Houghton BJ, Monson JP (1988) Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med 81:514\u2013516","journal-title":"J R Soc Med"},{"key":"126_CR5","first-page":"2865","volume":"81","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Ros\u00e9n T, Bosaeus I, Sj\u00f6str\u00f6m L, Bengtsson BA (1996) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865\u20132873. doi: 10.1210\/jc.81.8.2865","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR6","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-Haggstrom M, Mattsson A, Johannsson GJ (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961. doi: 10.1210\/jc.2006-0524","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1210\/jc.2004-2247","volume":"90","author":"A Colao","year":"2005","unstructured":"Colao A, Di Somma C, Rota F et al (2005) Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab 90:2056\u20132062. doi: 10.1210\/jc.2004-2247","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR8","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1210\/jcem-72-1-39","volume":"72","author":"NV Esteban","year":"1991","unstructured":"Esteban NV, Loughlin T, Yergey AZ et al (1991) Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry. J Clin Endocrinol Metab 72:1698\u20131700","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","volume":"4","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Doward LC, Alonso J et al (1999) The Qol-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 4:373\u2013338. doi: 10.1023\/A:1008987922774","journal-title":"Qual Life Res"},{"key":"126_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Rosen","year":"1990","unstructured":"Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285\u2013288. doi: 10.1016\/0140-6736(90) 91812-O","journal-title":"Lancet"},{"key":"126_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","volume":"42","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Freemantle C, Thomas E et al (1995) Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42:179\u2013189. doi: 10.1111\/j.1365-2265.1995.tb01860.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/jc.2003-030346","volume":"89","author":"AR Hoffman","year":"2004","unstructured":"Hoffman AR, Kuntze JE, Baptista J et al (2004) Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2048\u20132056. doi: 10.1210\/jc.2003-030346","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR13","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","volume":"90","author":"N Mauras","year":"2005","unstructured":"Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B, Transition Study Group (2005) Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 90:3946\u20133955. doi: 10.1210\/jc.2005-0208","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR14","first-page":"1668","volume":"83","author":"M Christopher","year":"1998","unstructured":"Christopher M, Hew FL, Oakley M, Rantzau C, Alford F (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24\u00a0months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 83:1668\u20131681. doi: 10.1210\/jc.83.5.1668","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","volume":"133","author":"G Sesmilo","year":"2000","unstructured":"Sesmilo G, Biller BM, Llevadot J et al (2000) Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111\u2013122","journal-title":"Ann Intern Med"},{"key":"126_CR16","first-page":"107","volume":"83","author":"RC Cuneo","year":"1998","unstructured":"Cuneo RC, Judd S, Wallace JD et al (1998) The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 83:107\u2013116. doi: 10.1210\/jc.83.1.107","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2005-0897","volume":"91","author":"RD Murray","year":"2006","unstructured":"Murray RD, Adams JE, Shalet SM (2006) A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. J Clin Endocrinol Metab 91:432\u2013438. doi: 10.1210\/jc.2005-0897","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2265.2005.02240.x","volume":"62","author":"C Ehrnborg","year":"2005","unstructured":"Ehrnborg C, Ellegard L, Bosaeus I, Bengtsson BA, Rosen T (2005) Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf) 62:449\u2013457. doi: 10.1111\/j.1365-2265.2005.02240.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR19","first-page":"1505","volume":"76","author":"JR Kerrigan","year":"1993","unstructured":"Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505\u20131510. doi: 10.1210\/jc.76.6.1505","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR20","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"Hahner S, Loeffler M, Fassnacht M et al (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92:3912\u20133922. doi: 10.1210\/jc.2007-0685","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.1995.tb02928.x","volume":"43","author":"FP Dunne","year":"1995","unstructured":"Dunne FP, Elliot P, Gammage MD et al (1995) Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol (Oxf) 43:623\u2013629. doi: 10.1111\/j.1365-2265.1995.tb02928.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR22","first-page":"1138","volume":"114","author":"MA Zeiger","year":"1993","unstructured":"Zeiger MA, Fraker DL, Pass HI et al (1993) Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 114:1138\u20131143","journal-title":"Surgery"},{"key":"126_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2265.1997.780907.x","volume":"46","author":"SR Peacey","year":"1997","unstructured":"Peacey SR, Guo CY, Robinson AM et al (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 46:255\u2013261. doi: 10.1046\/j.1365-2265.1997.780907.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, HyposCCS Advisory Board U.S. HypoCCS Study Group (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87:477\u2013485. doi: 10.1210\/jc.87.2.477","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","volume":"357","author":"I Ford","year":"2007","unstructured":"Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM, West of Scotland Coronary Prevention Study Group (2007) Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 357:1477\u20131486. doi: 10.1056\/NEJMoa065994","journal-title":"N Engl J Med"},{"key":"126_CR26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-57-3-619","volume":"57","author":"MR Taskinen","year":"1983","unstructured":"Taskinen MR, Nikkil\u00e4 EA, Pelkonen R, Sane T (1983) Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing\u2019s syndrome. J Clin Endocrinol Metab 57:619\u2013626","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2265.2003.01987.x","volume":"60","author":"M Krsek","year":"2004","unstructured":"Krsek M, Silha JV, Jezkov\u00e1 J et al (2004) Adipokine levels in Cushing\u2019s syndrome; elevated resistin levels in female patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 60:350\u2013357. doi: 10.1111\/j.1365-2265.2003.01987.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"126_CR28","first-page":"1078","volume":"87","author":"M Pirlich","year":"2002","unstructured":"Pirlich M, Biering H, Gerl H et al (2002) Loss of body cell mass in Cushing\u2019s syndrome: effect of treatment. J Clin Endocrinol Metab 87:1078\u20131084. doi: 10.1210\/jc.87.3.1078","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-008-0126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-008-0126-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-008-0126-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:08:07Z","timestamp":1559354887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-008-0126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s11102-008-0126-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,6]]}}}